Why was Covovax given a pass?

Why was Covovax given a pass?

Photo for representational purpose only.

Karan Thapar

The government’s choice of vaccines for the third jab raises questions that urgently call for an answer or, at least, a fuller explanation. So far, however, the silence from either the National Technical Advisory Group on Immunisation in India (NTAGI) or the Covid-19 Working Group suggests we are not going to be given one. So let me raise those questions in the hope it might provoke someone to respond. After all, as citizens of India, this is our right.

The government has decided to go with third jabs of the vaccines. We’ve already been ignoring two critical facts — there are no studies that assess the efficacy of a third jab of Covaxin, and so there’s no basis for making this choice; and, second, there is one very credible study by Southampton University, peer-reviewed by The Lancet, which says a Covovax third jab after two of AstraZeneca/Covishield will produce nearly three times more antibodies than a third jab of AstraZeneca/Covishield. In fact — and this is a point made by the study — half a Covovax is better than a full AstraZeneca/Covishield.

Now, Covovax, known abroad as Novovax, has already been cleared by the WHO and the EU. Second, according to multiple newspaper reports, there is no shortage of Covovax. It’s made by the Serum Institute which, as far back as June, said it could have 200 million doses available by December 2021. More importantly, it has already begun exporting — 50 million have been sent to Indonesia and the Philippines. More recently, 70 million were sent to the Netherlands, Australia and New Zealand. We need 130 million to cover all health workers, frontline workers and people over 60 with comorbidities, but not necessarily at one go. I don’t believe supply will be a problem. Which reinforces the question — why was Covovax not chosen?

Finally, if mRNA vaccines are the best third jabs, as the world believes, why are we denying them to our citizens? Pakistan and Bangladesh are both giving Pfizer. They have no problem with the immunity clause and after billions of Pfizer jabs have been given worldwide, surely this is now only a matter of detail or false national pride. Is it a good ground for denying the best third jab to Indian citizens?

These are questions that not only need to be answered, but also if they remain hanging in the air, they could soon become disturbing and distressing. I can’t believe the government doesn’t realise that. So, again, why is it silent?

My hunch is these are issues on which members of NTAGI and the Covid-19 Working Group have differences. In the interviews they’ve earlier given, they’ve spoken in different voices and come to contrasting conclusions. Now, after the announcement on Wednesday evening, interviews that had been repeatedly promised were inexplicably cancelled. Isn’t it odd that just when we need explanations those who can provide them no longer want to talk?

Tribune Shorts


Top Stories

SC upholds 27 pc OBC reservation in NEET all-India quota

Reservation not at odds with merit, says SC as it upholds 27 pc OBC quota in NEET

Top court says challenge to the validity of criteria for det...

Daughters to inherit fathers’ self acquired, inherited properties, to get preference over others: SC

Daughters to inherit fathers’ self acquired, inherited properties, to get preference over others: SC

Top court bench was dealing with the legal issue concerning ...

Covid deaths in third wave majorly lower than second due to high vaccine uptake

Covid deaths in third wave majorly lower than second due to high vaccine uptake

Bed occupancy in Delhi stable despite rise in new and active...

Masks not recommended for children aged 5 and under: New Covid guide on children

Masks not recommended for children aged 5 and under: New Covid guide on children

Issuing antimicrobial use guide, health ministry says Covid-...

Cities

View All